Eli Lilly and Co edged past Wall Street estimates for quarterly revenue on Tuesday, as higher sales of its top-selling diabetes drug, Trulicity, helped offset the impact of generic competition on its erectile dysfunction drug, Cialis.
Source:: Reuters – Business News
